X

Vous n'êtes pas connecté

Maroc Maroc - ZACKS.COM - All Stories - 12/Jul 13:52

Zacks Initiates Coverage of Elite Pharmaceuticals With Outperform Recommendation

Discover why Zacks rates Elite Pharmaceuticals as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore ELTP's strategic partnerships, financial health, and robust product pipeline.

Articles similaires

Sorry! Image not available at this time

Zacks Initiates Coverage of Precipio With Outperform Recommendation

zacks.com - 05/Sep 13:47

Discover why Zacks rates Precipio as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore PRPO's approaching...

Sorry! Image not available at this time

Zacks Initiates Coverage of Precipio With Outperform Recommendation

zacks.com - 05/Sep 13:47

Discover why Zacks rates Precipio as "Outperform", being the first on Wall Street to initiate coverage on the stock. Explore PRPO's approaching...

Sorry! Image not available at this time

Reasons Why Celestica Stock is a Buy - Beyond the 77% 1-Year Surge

zacks.com - 13:11

Riding on a robust earnings surprise history and favorable Zacks Rank, CLS appears primed for further stock price appreciation.

Sorry! Image not available at this time

Reasons Why Celestica Stock is a Buy - Beyond the 77% 1-Year Surge

zacks.com - 13:11

Riding on a robust earnings surprise history and favorable Zacks Rank, CLS appears primed for further stock price appreciation.

Sorry! Image not available at this time

Why Veeva (VEEV) International Revenue Trends Deserve Your Attention

zacks.com - 05/Sep 13:15

Review Veeva's (VEEV) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future...

Sorry! Image not available at this time

Why Veeva (VEEV) International Revenue Trends Deserve Your Attention

zacks.com - 05/Sep 13:15

Review Veeva's (VEEV) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future...

Sorry! Image not available at this time

Should You Invest in Commvault (CVLT) Based on Bullish Wall Street Views?

zacks.com - 02/Sep 13:30

Based on the average brokerage recommendation (ABR), Commvault (CVLT) should be added to one's portfolio. Wall Street analysts' overly optimistic...

Sorry! Image not available at this time

Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet

zacks.com - 30/Aug 13:30

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts...

Sorry! Image not available at this time

Is Deckers (DECK) a Buy as Wall Street Analysts Look Optimistic?

zacks.com - 29/Aug 13:30

Based on the average brokerage recommendation (ABR), Deckers (DECK) should be added to one's portfolio. Wall Street analysts' overly optimistic...